← All trials
NCT04111536
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2019
- Primary completion
- Apr 30, 2023
- Completion date
- Apr 30, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 28
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of PennsylvaniaLead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of PennsylvaniaOverall official - principal investigator
- University of PennsylvaniaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.